Instrument Inactif

Communiqués Aastrom Biosciences Inc Nasdaq

Actions

US00253U3059

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

16/09	Transcript : Vericel Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 02:35 PM
31/07	Vericel Corporation : Truist Securities optimiste sur le dossier	ZM

Communiqués

08/09	Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026	GL
30/07	Vericel : Q2 2026 Earnings Call Presentation	PU
30/07	Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program	GL
16/07	Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026	GL
09/06	Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026	GL
07/05	Vericel : Q1 2026 Earnings Call Presentation	PU
07/05	Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance	GL
23/04	Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026	GL
02/04	Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid	GL
04/03	Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility	GL
04/03	Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility	AQ
03/03	Vericel to Present at Multiple Upcoming Investor Conferences	GL
26/02	Vericel : Q4 2025 Earnings Call Presentation	PU
26/02	Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results	GL
12/02	Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026	GL
13/01	Vericel : Presentation JPMorgan Healthcare Conference January 14, 2026 FINAL No Speaker Notes	PU
13/01	Vericel Announces Preliminary 2025 Financial Results and Business Updates	GL
06/01	Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026	GL
14/11	Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025	GL
06/11	Vericel : Q3 2025 Earnings Call Presentation FINAL	PU
06/11	Vericel Reports Third Quarter 2025 Financial Results	GL
23/10/25	Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025	GL
28/08/25	Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025	GL
31/07/25	Vericel : Q2 2025 Earnings Call Presentation FINAL	PU
31/07/25	Vericel Reports Second Quarter 2025 Financial Results	GL